Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,489
archived clinical trials in
Endometrial Cancer

An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
UT Galveston; University of Texas Medical Branch (UTMB)
mi
from
Galveston, TX
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
UT Galveston; University of Texas Medical Branch (UTMB)
mi
from
Galveston, TX
Click here to add this to my saved trials
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
University of California - Irvine Healthcare
mi
from
Irvine, CA
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
University of California - Irvine Healthcare
mi
from
Irvine, CA
Click here to add this to my saved trials
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
University of Colorado School of Medicine, Division of Gynecologic Oncology
mi
from
Aurora, CO
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
University of Colorado School of Medicine, Division of Gynecologic Oncology
mi
from
Aurora, CO
Click here to add this to my saved trials
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Oklahoma Cancer Specialists and Research Institute, LLC
mi
from
Tulsa, OK
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Oklahoma Cancer Specialists and Research Institute, LLC
mi
from
Tulsa, OK
Click here to add this to my saved trials
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Seattle Cancer Care Alliance / University of Washington
mi
from
Seattle, WA
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Seattle Cancer Care Alliance / University of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Saint Alphonsus Regional Medical Center
mi
from
Boise, ID
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Saint Alphonsus Regional Medical Center
mi
from
Boise, ID
Click here to add this to my saved trials
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
A Phase I Trial of Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Recurrent or Refractory Gynecological Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
A Phase I Trial of Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Recurrent or Refractory Gynecological Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
A Phase I Trial of Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Recurrent or Refractory Gynecological Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
A Phase I Trial of Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Recurrent or Refractory Gynecological Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Scale Down for Endometrial Cancer
Scale Down: A Randomized, Controlled Weight Management Intervention for Women With Endometrial Cancer
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Scale Down for Endometrial Cancer
Scale Down: A Randomized, Controlled Weight Management Intervention for Women With Endometrial Cancer
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer
The Validity of Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer (EC)
Status: Enrolling
Updated:  12/31/1969
University of Miami
mi
from
Miami, FL
Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer
The Validity of Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer (EC)
Status: Enrolling
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Survivorship Promotion In Reducing IGF-1 Trial
Trial of Behavioral Weight Loss and Metformin Treatment to Lower Insulin Growth Factor in Cancer Survivors
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins ProHealth
mi
from
Baltimore, MD
Survivorship Promotion In Reducing IGF-1 Trial
Trial of Behavioral Weight Loss and Metformin Treatment to Lower Insulin Growth Factor in Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins ProHealth
mi
from
Baltimore, MD
Click here to add this to my saved trials
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Division of Gynecologic Oncology
mi
from
Saint Louis, MO
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Division of Gynecologic Oncology
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
East Carolina University School of Medicine
mi
from
Greenville, NC
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
East Carolina University School of Medicine
mi
from
Greenville, NC
Click here to add this to my saved trials
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Gynecologic Oncologists of NE Ohio
mi
from
Akron, OH
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Gynecologic Oncologists of NE Ohio
mi
from
Akron, OH
Click here to add this to my saved trials
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Simmons Cancer Center - Dallas
mi
from
Dallas, TX
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Simmons Cancer Center - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Texas Oncology, PA
mi
from
Dallas, TX
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Texas Oncology, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
A Phase I Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
Status: Enrolling
Updated:  7/15/2009
Yale University School of Medicine
mi
from
New Haven, CT
Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
A Phase I Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
Status: Enrolling
Updated: 7/15/2009
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Photoacoustic Endoscopy in Endometrial Cancer
A Pilot Study of Photoacoustic Endoscopy in Endometrial Cancer
Status: Enrolling
Updated:  12/22/2011
Washington University School of Medicine
mi
from
Saint Louis, MO
Photoacoustic Endoscopy in Endometrial Cancer
A Pilot Study of Photoacoustic Endoscopy in Endometrial Cancer
Status: Enrolling
Updated: 12/22/2011
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Psychosocial Benefits of Exercise in Endometrial Cancer Survivors
Psychosocial Benefits of Exercise in Endometrial Cancer Survivors
Status: Enrolling
Updated:  2/24/2012
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Psychosocial Benefits of Exercise in Endometrial Cancer Survivors
Psychosocial Benefits of Exercise in Endometrial Cancer Survivors
Status: Enrolling
Updated: 2/24/2012
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
St. Joseph's Hospital & Medical Center St Jospeh's
mi
from
Phoenix, AZ
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
St. Joseph's Hospital & Medical Center St Jospeh's
mi
from
Phoenix, AZ
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Highlands Oncology Group Dept of Highlands Oncology Grp
mi
from
Fayetteville, AR
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Highlands Oncology Group Dept of Highlands Oncology Grp
mi
from
Fayetteville, AR
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
City of Hope National Medical Center City of Hope national Med Ctr
mi
from
Duarte, CA
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
City of Hope National Medical Center City of Hope national Med Ctr
mi
from
Duarte, CA
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
H. Lee Moffitt Cancer Center/University of South Florida Moffitt 3
mi
from
Tampa, FL
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
H. Lee Moffitt Cancer Center/University of South Florida Moffitt 3
mi
from
Tampa, FL
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Holy Cross Hospital Holly Cross
mi
from
Silver Spring, MD
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Holy Cross Hospital Holly Cross
mi
from
Silver Spring, MD
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Henry Ford Hospital Henry Ford
mi
from
Detroit, MI
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Henry Ford Hospital Henry Ford
mi
from
Detroit, MI
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Washington University School Of Medicine-Siteman Cancer Ctr Wash U
mi
from
St. Louis, MO
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Washington University School Of Medicine-Siteman Cancer Ctr Wash U
mi
from
St. Louis, MO
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Morristown Memorial Hospital MMH
mi
from
Morristown, NJ
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Morristown Memorial Hospital MMH
mi
from
Morristown, NJ
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Carolinas HealthCare Systems Blumenthal Cancer Center
mi
from
Charlotte, NC
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Carolinas HealthCare Systems Blumenthal Cancer Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Cancer Centers of North Carolina Cancer Centers of NC-Raleigh
mi
from
Raleigh, NC
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Cancer Centers of North Carolina Cancer Centers of NC-Raleigh
mi
from
Raleigh, NC
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
University of Oklahoma Health Sciences Center OU Health
mi
from
Oklahoma City, OK
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
University of Oklahoma Health Sciences Center OU Health
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Oregon Health & Science University (OHSU)
mi
from
Portland, OR
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Oregon Health & Science University (OHSU)
mi
from
Portland, OR
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Northwest Cancer Specialists Vancouver Location
mi
from
Portland, OR
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Northwest Cancer Specialists Vancouver Location
mi
from
Portland, OR
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Geisinger Health System GHS
mi
from
Danville, PA
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Geisinger Health System GHS
mi
from
Danville, PA
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Sarah Cannon Research Institute SCRI (2)
mi
from
Nashville, TN
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Sarah Cannon Research Institute SCRI (2)
mi
from
Nashville, TN
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Texas Oncology, P.A. Austin
mi
from
Bedford, TX
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Texas Oncology, P.A. Austin
mi
from
Bedford, TX
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Texas Oncology, P.A. Tex Onc (3)
mi
from
Bedford, TX
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Texas Oncology, P.A. Tex Onc (3)
mi
from
Bedford, TX
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
University of Texas Southwestern Medical Center Obstetrics and Gynecology
mi
from
Dallas, TX
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
University of Texas Southwestern Medical Center Obstetrics and Gynecology
mi
from
Dallas, TX
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
US Oncology Central Monitoring
mi
from
Dallas, TX
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
US Oncology Central Monitoring
mi
from
Dallas, TX
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
South Texas Oncology and Hematology, PA South Tex Onc
mi
from
San Antonio, TX
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
South Texas Oncology and Hematology, PA South Tex Onc
mi
from
San Antonio, TX
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Pacific Gynecology Specialists PGS
mi
from
Seattle, WA
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Pacific Gynecology Specialists PGS
mi
from
Seattle, WA
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Cancer Care Northwest CC Northwest- Spokane South(3)
mi
from
Spokane, WA
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Cancer Care Northwest CC Northwest- Spokane South(3)
mi
from
Spokane, WA
Click here to add this to my saved trials
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
A Phase 1, Open-Label, Multiple-Escalating-Dose Study of DS-7423, an Orally Administered Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  4/24/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
A Phase 1, Open-Label, Multiple-Escalating-Dose Study of DS-7423, an Orally Administered Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 4/24/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
A Phase 1, Open-Label, Multiple-Escalating-Dose Study of DS-7423, an Orally Administered Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  4/24/2013
Clinical Research Facility
mi
from
New York, NY
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
A Phase 1, Open-Label, Multiple-Escalating-Dose Study of DS-7423, an Orally Administered Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 4/24/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
A Phase 1, Open-Label, Multiple-Escalating-Dose Study of DS-7423, an Orally Administered Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  4/24/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
A Phase 1, Open-Label, Multiple-Escalating-Dose Study of DS-7423, an Orally Administered Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 4/24/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
Detection of Sentinel Lymph Nodes in Patients With Endometrial Cancer Undergoing Robotic-Assisted Staging: Comparison of Isosulfan Blue and Indocyanine Green Dyes With Fluorescence Imaging
Status: Enrolling
Updated:  2/20/2014
Florida Hospital Gynecologic Oncology
mi
from
Orlando, FL
Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
Detection of Sentinel Lymph Nodes in Patients With Endometrial Cancer Undergoing Robotic-Assisted Staging: Comparison of Isosulfan Blue and Indocyanine Green Dyes With Fluorescence Imaging
Status: Enrolling
Updated: 2/20/2014
Florida Hospital Gynecologic Oncology
mi
from
Orlando, FL
Click here to add this to my saved trials
Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer
A Phase 0 Pharmacodynamic Study of Dasatinib in Women With Newly Diagnosed Endometrial Cancer
Status: Enrolling
Updated:  6/5/2014
University of Virginia
mi
from
Charlottesville, VA
Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer
A Phase 0 Pharmacodynamic Study of Dasatinib in Women With Newly Diagnosed Endometrial Cancer
Status: Enrolling
Updated: 6/5/2014
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials